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CORRESPONDENCE
Further characterization of complex chromosomal rearrangements in myeloid
malignancies: spectral karyotyping adds precision in defining abnormalities associated
with poor prognosis
TO THE EDITOR
In the last 30 years, information provided by cytogenetic analysis has
become indispensable for the clinical management of patients with
hematological malignancies. In acute myeloid leukemia (AML), the
favorable prognostic subgroup is defined by the presence of leukemic
blasts with t(15;17), t(8;21), or inv(16). The unfavorable cases are
those with abnormalities involving more than two chromosomes,
monosomy 5/5q- or 7/7q- , or rearrangements of the long arm of chro-
mosome 3. The survival rate of this group is less than 20% at 5 years.
These patients represent a considerable therapeutic challenge for
whom no current treatment approach is satisfactory.1 The patients
with a normal karyotype or cytogenetic abnormalities that are not
included in these other categories are characterized as having an
intermediate risk of relapse.1,2 In myelodysplastic syndromes (MDS),
abnormalities of 7q or a complex karyotype are also unfavorable prog-
nostic factors.3 Improvements in treatment of AML, t-AML and MDS
have resulted in high complete remission rates even in patients with
unfavorable cytogenetics; however, the majority of patients relapse.1,3
Therefore, further genetic studies redefining the patients included in
the poor prognostic group are necessary.
In order to characterize the karyotype more precisely, we analyzed
18 samples from patients with myeloid malignancies and a complex
karyotype using three different techniques: G-banding, fluorescence
in situ hybridization (FISH), and spectral karyotyping (SKY). The SKY
probe mixture and hybridization reagents were obtained from Applied
Spectral Imaging (Carlsbad, CA, USA). Slides for spectral karyotyping
were hybridized as previously described.4 For analysis of cases that
had complex markers or non-obvious chromosome rearrangements,
FISH experiments were performed using the appropriate painting or
centromere-specific probes (Vysis, Downers Grove, IL, USA).
All 18 cases were successfully analyzed using SKY. In the three
cases with complete G-band analysis (cases 6, 8, 14), SKY confirmed
the G-banding results. In the other 15 cases, the use of SKY substan-
tially improved the precision of karyotype analysis of malignant cells,
detecting several unexpected aberrations. The approach of combining
three different cytogenetic techniques allowed the identification of
hidden translocations and the reconstruction of complex rearrange-
ments. The complete karyotypes after the combined analysis are given
in Table 1. Deletions and unbalanced translocations in samples with
complex aberrations were particularly prone to misinterpretation
based on G-banding alone, especially when chromosomal regions
that have a similar G-banding pattern were involved. In 13 cases (1,
2, 4, 5, 7, 9, 11, 12, 13, 15, 16, 17, 18), chromosome material from
total or partial monosomies detected by G-banding was found in
derivative or marker chromosomes. On the other hand, in seven cases
(7, 9, 11, 13, 15, 16, 18) deletions were actually found to be translo-
cations after SKY. This is especially important in cases with aberrations
with prognostic significance. Thirteen cases (72%) had monosomy 5
or 7, or abnormalities of 3q, 5q or 7q. SKY confirmed the G-banding
results in six of these cases and detected new abnormalities in seven
others. Three of our cases were - 5 (cases 7, 9 and 13); based on SKY,
all three were changed to a deletion 5q, eg loss of chromosome 5,
bands 5q31 to 5q33 (case 7); translocation of parts of 5 to a der(7)
and a der(13), that resulted in loss of chromosome 5, bands 5q13 to
5q33, in case 9. In case 13, 5q was thought to be on chromosome
18, however, SKY demonstrated that a der(5), chromosome break in
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5q13, was joined to 17q. SKY confirmed the del(5q) in four cases (2,
3, 4, 15) and clarified the nature of the 5;17 rearrangement in a fifth
case (case 5). In case 11, del(5)(q15q33) was shown to involve a 5;6
translocation with a deletion of part of 5q in this process (Figure 1).
In case 16, the add(5)(q13) was really a der(5)t(2;5)(p25;q13). Minus
5 is associated with a dismal prognosis.2 Therefore modifying the
analysis could move these patients from an extremely poor prognosis
to one that is less poor. Eight patients had - 7; SKY confirmed this in
six patients and revealed that part of 7 was on a der(6) (case 9) or a
der(15) (case 13). The analysis in each of the three cases (7,11,16)
with a del(7q) or ring chromosome was modified based on SKY
(Table 1).
Other studies using SKY have shown its power in resolving the full
spectrum of chromosome abnormalities in tumors, as well as docu-
menting new recurring breakpoints in lymphoproliferative disorders.4–6
Two recent papers have focused on the ability of this technique to
detect hidden aberrations in myeloproliferative disorders,7,8 but this
is the first report focusing on a group of myeloid malignancies with
poor outcome. The results of Mohr et al7 and Zhang et al8 showed
SKY could identify undetected cytogenetic aberrations in only two of
47 karyotypically normal AML. These results, and the fact this is a
laborious and expensive technique, suggest that SKY is not likely to
have a clinical impact for the study of normal G-banding cases.
Although SKY did not detect any unexpected recurring aberrations in
the cases we studied, our work confirms that this technique is a useful
tool to resolve uncertainties of the G-banding analysis in cases with
complex karyotypes. A recent report has shown yet again the impor-
tance of karyotype as a critical independent determinant of outcome
in AML, especially in older patients.2 Our study shows SKY could
provide further precision to refine the poor prognostic groups in
myeloid malignancies. As indicated by others, this technique should
be used to complement G-banding analysis.4,5 The conventional kary-
otype provides an accurate description of the bands involved in the
rearrangements and permits an analysis of a larger number of clones.
In many rearrangements the breakpoints on the SKY-painted chromo-
somes were identified by comparing the corresponding DAPI banding
and G-banded karyotype of the same tumor (Figure 1).
In conclusion, SKY can be an important tool to characterize aber-
rations in cases with complex karyotypes. The detection of subtle
translocations in chromosomes thought to be deletions using G-band-
ing shows that SKY can provide a focus for further FISH and molecular
studies, especially in cases with 3q, 5q and 7q rearrangements. More-
over, SKY and other techniques of molecular cytogenetics, could help
to identify specific subtypes of the disease with prognostic signifi-
cance. Further studies in a larger number of cases are needed to show
if any of the translocations found are recurrent, and to supply critical
information on the correct implication of monosomy in myeloid
malignancies.
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Figure 1 SKY analysis of case 11 (clone 4). (a) Spectral metaphase.
(b) Classified metaphase. (c) Partial G-band and SKY karyotypes illus-
trating the power of the combined approach to clarify complex chro-
mosome rearrangements. Normal homologues are included whenever
possible to facilitate comparison. See text for detailed karyotype
description.
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Abnormalities of the p16INK4a gene in childhood B-precursor acute lymphoblastic
leukemia without nonrandom translocations: analysis of seven matched pairs of
primary leukemia and corresponding cell line
TO THE EDITOR
Progression of the cell cycle in eukaryotic cells is strictly and skillfully
regulated by the sequential formation, activation, and subsequent
inactivation of a series of cyclin and cyclin-dependent kinase (CDK)
complexes. The activation of CDK4 and CDK6 by cyclin D elicits
phosphorylation of retinoblastoma protein (pRB), which results in
release of several pRB-associated transcription factors required for G1
to S phase progression. Among a family of proteins that bind and
inhibit CDKs, p16INK4a specifically blocks the activity of CDK4 and
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CDK6 ultimately resulting in inhibition of cell division. The p16 gene
located on chromosomal region 9p21 appears to be inactivated in a
wide variety of tumors, and mice carrying a targeted deletion of p16
demonstrate development of spontaneous tumors at a high rate, sug-
gesting that p16 could be a tumor suppressor. The human p16 gene
locus encodes a second protein p14ARF via transcription of an alterna-
tive first exon and common exon 2 in different reading frame. This
protein does not directly bind and inhibit CDKs but appears to
enhance the functional activity of wild-type p53. Because mice with
disrupted p19ARF (the mouse homologue of p14ARF) but intact p16
expression have a susceptibility to cancer, p14ARF is considered as
another tumor suppressor. Among mechanisms that inactivate p16 in
tumor cells, homozygous deletion may predominantly contribute to
tumorigenesis or disease progression, because this inactivates both
p16 and p14ARF that act upstream of pathways involving pRB and p53,
respectively. However, there are some controversies regarding the sig-
